John A Orwin Insider Trading $SGEN Seagen Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John A Orwin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John A Orwin. John A Orwin is in ARRAY BIOPHARMA INC ($ARRY) and Director in ARRAY BIOPHARMA INC ($ARRY) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in NeurogesX Inc ($NGSX) and President & CEO in Relypsa Inc ($RLYP) and Director in Retrophin, Inc. ($RTRX) and President & CEO in Atreca, Inc. ($BCEL).
John A Orwin in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John A Orwin: Director
Holdings: 26,098 shares
Current Value: $1,586,497
Latest Transaction: May 19 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John A Orwin in Seagen Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARRY, BCEL, NGSX, RLYP, SGEN, RTRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Option Exercise | A | 160.33 | 3,171 | 508,406 | 3,171 | |
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Grant | A | 0.00 | 1,335 | 0 | 26,098 | 24.8 K to 26.1 K (+5.39 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Grant | A | 0.00 | 2,963 | 0 | 24,763 | 21.8 K to 24.8 K (+13.59 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Grant | A | 0.00 | 2,963 | 0 | 24,763 | 21.8 K to 24.8 K (+13.59 %) |
| May 22 2018 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
| May 22 2018 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Grant | A | 0.00 | 3,700 | 0 | 21,800 | 18.1 K to 21.8 K (+20.44 %) |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Grant | A | 0.00 | 3,700 | 0 | 18,100 | 14.4 K to 18.1 K (+25.69 %) |
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Option Exercise | A | 38.82 | 9,260 | 359,473 | 9,260 | |
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Grant | A | 0.00 | 3,700 | 0 | 14,400 | 10.7 K to 14.4 K (+34.58 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Buy | P | 28.33 | 2,000 | 56,660 | 10,700 | 8.7 K to 10.7 K (+22.99 %) |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Option Exercise | A | 39.94 | 9,260 | 369,844 | 9,260 | |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Grant | A | 0.00 | 3,700 | 0 | 8,700 | 5 K to 8.7 K (+74.00 %) |
Page: 1